• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国际组织在防止假冒药品进入世界市场方面的作用。

ROLE OF THE INTERNATIONAL ORGANIZATIONS IN PREVENTING THE COUNTERFEIT MEDICINES ENTRY INTO THE WORLD MARKETS.

作者信息

Stukina Valeryia, Dohnal Jiri, Saloun Jan

出版信息

Acta Pol Pharm. 2016 Sep;73(5):1381-1388.

PMID:29638079
Abstract

30 years have passed since Conference of Experts on the Rational Use of Drugs was held in Nairobi, Kenya, from 25 to 29 November 1985, where the problem of counterfeit medicines was mentioned as the international for the first time. The problem of counterfeit medicines is not only a major threat to public health and national and private economy, but also it is of great interest for key decision-making actors at the international level. The authors analyzed what has been done since that time by international organizations. Combating the counterfeiting of medicines cannot be successfully achieved by the health sector alone - World Health Organization (WHO), - so the efforts of the other United Nations (UN) organizations relevant to counterfeiting were in need and were studied in the article: World Intellectual Property Organization (WIPO), World Trade Organization (WTO), World Customs Organization (WCO), United Nations Office on Drugs and Crime (UNODC), etc. Today WHO is unable to coordinate all their activities, so the few existing proposals for establishing a new mechanism of international cooperation have been examined. Will the MEDICRIME Convention that will enter into force on January 1, 2016 be the start of the new era in the combating with the counterfeit medicines? - the authors offered their vision on the international developments.

摘要

1985年11月25日至29日,合理用药专家会议在肯尼亚内罗毕召开,自那时起已过去30年。在那次会议上,假药问题首次作为一个国际性问题被提及。假药问题不仅对公众健康以及国家和私营经济构成重大威胁,而且也引起了国际层面关键决策行为体的极大关注。作者分析了自那时以来国际组织所采取的行动。仅靠卫生部门(世界卫生组织)无法成功打击假药行为,因此本文研究了联合国其他与打击假药相关的组织的努力,这些组织包括世界知识产权组织、世界贸易组织、世界海关组织、联合国毒品和犯罪问题办公室等。如今,世界卫生组织无法协调它们所有的活动,因此作者审视了现有的几项关于建立新的国际合作机制的提议。将于2016年1月1日生效的《反假药公约》会成为打击假药新时代的开端吗?作者阐述了他们对国际形势发展的看法。

相似文献

1
ROLE OF THE INTERNATIONAL ORGANIZATIONS IN PREVENTING THE COUNTERFEIT MEDICINES ENTRY INTO THE WORLD MARKETS.国际组织在防止假冒药品进入世界市场方面的作用。
Acta Pol Pharm. 2016 Sep;73(5):1381-1388.
2
Fighting trafficking of falsified and substandard medicinal products in Russia.打击俄罗斯假药和劣药的非法交易。
Int J Risk Saf Med. 2015;27 Suppl 1:S37-40. doi: 10.3233/JRS-150681.
3
Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism.加强全球卫生治理以打击假药:关于设立毒品和犯罪问题办公室-世卫组织-国际刑警组织三边机制的建议。
BMC Med. 2013 Oct 31;11:233. doi: 10.1186/1741-7015-11-233.
4
[Counterfeit medicines--Japan and the world].[假药——日本与世界]
Yakugaku Zasshi. 2014;134(2):213-22. doi: 10.1248/yakushi.13-00230-3.
5
Combating counterfeit medicines and illicit trade in tobacco products: minefields in global health governance.打击假药和烟草制品非法贸易:全球卫生治理中的雷区。
J Law Med Ethics. 2012 Summer;40(2):326-47. doi: 10.1111/j.1748-720X.2012.00667.x.
6
Falsification of medical products: criminal law mechanism combating threats to public health.医疗产品造假:打击对公众健康威胁的刑法机制
Wiad Lek. 2019;72(5 cz 1):856-861.
7
Combating poor-quality anti-malarial medicines: a call to action.打击劣质抗疟药物:行动呼吁。
Malar J. 2016 Jun 1;15:302. doi: 10.1186/s12936-016-1357-8.
8
Globalisation of international health.国际卫生的全球化
Lancet. 1998 Feb 7;351(9100):434-7. doi: 10.1016/S0140-6736(97)05546-3.
9
Do international model drug control laws provide for drug availability?国际示范毒品管制法是否规定了毒品的可获得性?
J Pain Palliat Care Pharmacother. 2009;23(2):145-52. doi: 10.1080/15360280902900729.
10
[Counterfeit Medicines in Internet and the Fakeshare European Project: Experiences and Activities in Spain].[互联网上的假药与欧洲假药共享项目:西班牙的经验与活动]
Rev Esp Salud Publica. 2016 Aug 16;90:e1-e14.

引用本文的文献

1
Analysis of pharmacovigilance databases for spontaneous reports of adverse drug reactions related to substandard and falsified medical products: A descriptive study.对药物警戒数据库中与不合格和伪造医疗产品相关的药品不良反应自发报告的分析:一项描述性研究。
Front Pharmacol. 2022 Sep 6;13:964399. doi: 10.3389/fphar.2022.964399. eCollection 2022.